Corona vaccine: Pfizer claims to be 95 percent safe in the third phase of the trial
In the next few days, the way will be open to applying to the US regulator for final approval.
The American vaccine company and its partner Bioentech SE said the vaccine has been shown to be effective in people of all age groups.
It is said that no serious problem has emerged from this. About 44,000 people were vaccinated in the trial.
Pfizer's stock has risen 2.7 percent in the pre-market with this claim. Shares of Bioentech also rose 7.3 percent.
No comments